Cerevance establishes strategic research collaboration with Merck by John Pinching | Aug 10, 2022 | News | 0 Partnership will focus on the discovery of novel targets in Alzheimer’s disease Read More
Positive results for Cerevance’s Parkinson’s drug by John Pinching | Mar 31, 2022 | News | 0 In phase 2 trials, the drug reduced ‘OFF time’ which refers to periods of the day when Parkinson’s symptoms recur despite medication Read More